{
    "N/R/U": null,
    "Applicant": "Merck Sharp & Dohme LLC",
    "BLA Number": "103949",
    "Proprietary Name": "Sylatron",
    "Proper Name": "peginterferon alfa-2b",
    "BLA Type": "351(a)",
    "Strength": "300MCG",
    "Dosage Form": "For Injection",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Disc",
    "Licensure": "Voluntarily Revoked",
    "Approval Date": "29-Mar-11",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "5153",
    "Submission Type": "Supplement",
    "License Number": "2",
    "Product Number": "3",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "peginterferon alfa-2b",
            "drugbank_id": "DB00022"
        }
    ]
}